# Honeywell International Inc: Form 10-K for the period ended Dec 31, 2025

- Company: [Honeywell International Inc](/companies/hon.md) (CIK 773840)
- Form: 10-K
- Filed: 2026-02-17
- Accepted by EDGAR: Feb 17, 2026, 06:07 ET
- Period: 2025-12-31
- Accession: 0000773840-26-000013
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/773840/000077384026000013/hon-20251231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/773840/000077384026000013/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2025-10-01 to 2025-12-31 | $9.76bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 12 months, 2025-01-01 to 2025-12-31 | $37.44bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months, 2025-01-01 to 2025-12-31 | $23.61bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2025-10-01 to 2025-12-31 | $3.47bn | us-gaap:GrossProfit |
| Research and development | 12 months, 2025-01-01 to 2025-12-31 | $1.81bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months, 2025-01-01 to 2025-12-31 | $5.45bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2025-01-01 to 2025-12-31 | $8.13bn | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months, 2025-01-01 to 2025-12-31 | $1.01bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2025-10-01 to 2025-12-31 | −$115.0m | us-gaap:NetIncomeLoss |
| Net income | 12 months, 2025-01-01 to 2025-12-31 | $4.73bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2025-10-01 to 2025-12-31 | −$0.18 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months, 2025-01-01 to 2025-12-31 | $7.36 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2025-10-01 to 2025-12-31 | −$0.18 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months, 2025-01-01 to 2025-12-31 | $7.40 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2025-01-01 to 2025-12-31 | 642,800,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2025-01-01 to 2025-12-31 | $6.41bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2025-01-01 to 2025-12-31 | $986.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months, 2025-01-01 to 2025-12-31 | $2.98bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months, 2025-01-01 to 2025-12-31 | $3.80bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2025-12-31 | $12.49bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2025-12-31 | $30.39bn | us-gaap:AssetsCurrent |
| Total assets | at 2025-12-31 | $73.68bn | us-gaap:Assets |
| Current liabilities | at 2025-12-31 | $23.41bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2025-12-31 | $29.05bn | us-gaap:LongTermDebt |
| Short-term borrowings | at 2025-12-31 | $5.89bn | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2025-12-31 | $13.90bn | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/773840/000077384026000013/hon-20251231.htm

Filed Feb 17, 2026.
Source: SEC EDGAR, the filing index for accession 0000773840-26-000013. Last ingested by Listed: Nov 2, 2026, 18:46 ET. No prices; not investment advice.